Campbell & Co Investment Adviser’s Edwards Lifesciences EW Stock Holding History

Campbell & Co Investment Adviser’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,409	Closed	-$1.12M	–	1210
2025 Q3	$1.12M	Sell	14,409 -6,336	-31%	-$495K	0.08%	378
2025 Q2	$1.62M	Buy	+20,745	New	+$1.55M	0.1%	304
2024 Q4	–	Sell	-3,084	Closed	-$204K	–	1138
2024 Q3	$204K	Buy	+3,084	New	+$224K	0.02%	1014
2023 Q4	–	Sell	-3,434	Closed	-$238K	–	1168
2023 Q3	$238K	Sell	3,434 -415	-11%	-$33.4K	0.03%	799
2023 Q2	$363K	Buy	+3,849	New	+$335K	0.06%	580
2023 Q1	–	Sell	-3,205	Closed	-$239K	–	874
2022 Q4	$239K	Buy	+3,205	New	+$247K	0.06%	627
2019 Q2	–	Sell	-8,589	Closed	-$548K	–	576
2019 Q1	$548K	Buy	+8,589	New	+$490K	0.27%	93
2017 Q4	–	Sell	-30,291	Closed	-$1.1M	–	432
2017 Q3	$1.1M	Buy	+30,291	New	+$1.16M	0.89%	9
2017 Q2	–	Sell	-10,950	Closed	-$343K	–	337
2017 Q1	$343K	Buy	+10,950	New	+$343K	0.89%	38
2014 Q3	–	Sell	-22,164	Closed	-$317K	–	209
2014 Q2	$317K	Buy	+22,164	New	+$300K	0.13%	139

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Campbell & Co Investment Adviser's EW Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 14,409 shares — an estimated $1.12M sold.

Campbell & Co Investment Adviser first reported a position in EW in Q2 2014 and held it in 10 quarters. The position peaked at $1.62M in Q2 2025. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 14,409 Edwards Lifesciences shares in Q4 2025, an estimated $1.12M.
Campbell & Co Investment Adviser first reported a position in Edwards Lifesciences in Q2 2014 and held it in 10 quarters.
Campbell & Co Investment Adviser's Edwards Lifesciences position peaked at $1.62M in Q2 2025.
1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.